Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06016478 · ClinicalTrials.gov registry record · NA

The Effect of 4 Weeks of L-Citrulline Supplementation on Macro- and Microvascular Function in Type 2 Diabetes

A NA study of Type 2 Diabetes, sponsored by Texas Tech University.

Completed
Registry status
NA
Development phase
36
Enrollment target
1
Study location

NCT06016478 is a NA study of Type 2 Diabetes that has completed, run by Texas Tech University. The registered enrollment target is 36 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06016478, a NA study of Type 2 Diabetes, has completed, sponsored by Texas Tech University.

COMPLETED
Registry status
NA
Development phase
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the effect of 4 weeks of Citrulline supplementation on macro- and microvascular function during acute hyperglycemia in middle-aged and older adults with type 2 diabetes.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT L-citrulline

Study Locations (1)

Texas

  • TTU Kinesiology and Sport Management Building - Lubbock

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2023-05-01
Est. Completion 2024-07-01
Phase NA

Sponsor

Texas Tech University

69 total trials

What the Registry Record Tells You About NCT06016478

The ClinicalTrials.gov registry entry for NCT06016478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (97% lower). The listed sponsor is Texas Tech University, which has 69 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT06016478 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT06016478 about?

NCT06016478 is a clinical study titled "The Effect of 4 Weeks of L-Citrulline Supplementation on Macro- and Microvascular Function in Type 2 Diabetes". The purpose of this study is to examine the effect of 4 weeks of Citrulline supplementation on macro- and microvascular function during acute hyperglycemia in middle-aged and older adults with type 2 diabetes.

What is the current status of trial NCT06016478?

This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-05-01. Estimated completion is 2024-07-01.

What conditions does trial NCT06016478 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT06016478?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), L-citrulline (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06016478?

This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06016478 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.